E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Journal Browser

Journal Browser

Genes Upcoming Events Announce Your Event Here

25–26 April 2017 Precision Medicine Congress

London, UK

Oxford Global Conferences are proud to present the Inaugural Precision Medicine Congress, taking place on the 25-26 April 2017 in London.

175 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies

Over 20 presentations and case studies focusing on the key developments in precision medicine discovery, diagnostics, clinical development and genomics.

2 interactive streams:

  • Precision Medicine and Diagnostics in discovery and development
  • Precision Medicine and Genomics

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our Advances in Companion Diagnostics Congress

Free Pre-Congress Webinar

  1. Precision Medicine and Genomic Testing in both Cancer and Inherited Disease

Thursday 23rd February, 2017 3:00 PM GMT

Register for free today http://bit.ly/2e1dCHo

http://bit.ly/2cBHuNN

10–11 May 2017 Genome Editing USA Congress

Boston, MA, USA

Genome Editing USA Congress:

Oxford Global is proud to present its Inaugural Genome Editing USA Congress, on the 10-11 May 2017 in Boston.

Over two days our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss therapeutic and drug discovery applications, as well as novel gene-editing techniques and technologies. This event provides an ideal platform to participate in formal 1-2-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. 

The conference programme will consist of 3 interactive streams covering: 

  • Genome Editing Technologies
  • Drug Discovery & Development Applications
  • Therapeutic Applications of Genome Editing 

To download the conference programme please click here. (Please could you link ‘click here’ to: http://www.genomeeditingusa-congress.com/download-agenda/

Contact Danielle Dalby for further information. d.dalby@oxfordglobal.co.uk | +44(0)1865 248455

http://www.genomeeditingusa-congress.com

10–11 May 2017 Advances in Transgenic Technology USA Congress

Boston, MA, USA

Advances in Transgenic Technology USA Congress:

Oxford Global are proud to present our unmissable Advances in Transgenic Technology Congress, taking place on the 10-11 May 2017 in Boston.  

Over 200 senior level attendees, covering the hottest topic areas. Due to an increased sophistication in new technology becoming more widely available to researchers such as CRISPR, the transgenic market has grown significantly. 

  • On day one, our esteemed speakers will discussing state-of-the-art technologies for transgenic genome editing including CRISPR-Cas and genotyping strategies and tools technology focused workshops.
  • Day two of the congress presentations will focus on genetics and stem cell manipulation including pluripotent stem cell-based disease models and somatic cell nuclear transfer. Presentations will also cover novel transgenic technologies including novel implantation and injection systems. 

To download the conference programme please click here. (Please could you link ‘click here’ to: http://www.genomeeditingusa-congress.com/request-prices-agenda-transgenic-usa/ )

 TContact Danielle Dalby for further information. d.dalby@oxfordglobal.co.uk | +44(0)1865 248455

http://www.genomeeditingusa-congress.com/request-prices-agenda-transgenic-usa/

6–8 June 2017 CROPS 2017

Huntsville, AL, USA

CROPS 2017 is an international conference hosted by the HudsonAlpha Institute for Biotechnology and The University of Georgia.  This conference brings together leading genomic researchers and plant breeders to explore emerging applications of new genomic technology to crop improvement.

http://www.CROPSconference.org

12–13 June 2017 Oxford Global’s - 18th Annual Drug Discovery Leaders’ Summit

Hotel Palace, Berlin, Germany

This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field. 

 

8 interactive streams: 

  • Drug Discovery Innovation and Strategies, Enabling Technologies
  • Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
  • Successful Phenotypic Drug Discovery: High Content Screening
  • RNAi Screening, Cancer Genomics and Gene Editing for Drug Discovery
  • Discovery Chemistry, Medicinal and Computational Chemistry
  • Medicinal Chemistry and Drug Design: Novel Approaches.

Agenda: http://bit.ly/2dUjWB5

Free Pre-Congress Webinars

Drug Discovery Open Innovation & Outsourcing
Hosted by Patrick Kleyn, Director of Drug Target Innovation, EMD Serono
Register for Free Today

Phenotypic Screening in Drug Discovery- Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee
Register for Free Today

Disruptive Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals
Register for Free Today

For further information on the congress and the webinars, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0) 1865 248 455.

http://bit.ly/2dUjWB5

12–13 June 2017 Microbiome Discovery and Development Congress

Berlin Germany

Oxford Global is proud to present the Microbiome Discovery and Development Congress taking place on 12 – 13 June 2017 in Berlin, Germany. This exciting conference showcases world-class speakers discussing novel strategies in microbiome research, challenges of commercialising the microbiome and latest therapeutic trends.

Including 3 Interactive Streams:

  • Microbiome Discovery: Novel Strategies and Technologies
  • Commercialising the Microbiome
  • Therapeutic Potential of the Microbiome

 

View the Agenda: http://bit.ly/2hC8ICR

Free Live Webinar:
Antibiotics & the Microbiome: Protection of the Gut Microbiome from Antibiotics
Hosted by Jean de Gunzburg, CSO, Da Volterra
Register for Free Today: http://bit.ly/2gI1USa

http://bit.ly/2hC8ICR

19–21 June 2017 2017 IMB Conference: Gene Regulation by the Numbers: Quantitative Approaches to Study Transcription

Institute of Molecular Biology (IMB), Mainz, Germany

Key words: Molecular biology, genetics, epigenetics, DNA, RNA, gene regulation, bioinformatics, computational biology, transcription

Keynote speakers:

  • Eileen Furlong, European Molecular Biology Institute (EMBL), Heidelberg, Germany
  • Amos Tanay, The Weizmann Institute, Rehovot, Israel  

Summary of our conference

The focus of the 2017 IMB Conference is on “Gene Regulation by the Numbers: Quantitative Approaches to Study Transcription”. Our conference will explore the latest findings and technological developments in the field of gene regulation. The regulation of gene expression is a highly complex process in which numerous different factors play a role, such as signalling pathways, transcription factors and epigenetic modifications. With the recent surge in the development of omics technologies, researchers have generated vast amounts of data describing the contribution of these factors to controlling gene activity. However, interpreting, validating and integrating the data remains a major challenge. A combination of quantitative analysis and experimental research is therefore crucial to draw a complete picture of gene regulation.

The conference will address major open questions in the field that quantitative approaches will help to address, for example:

  • How do gene regulatory networks make robust decisions in the face of intracellular and environmental fluctuations?
  • How do epigenetic mechanisms ensure that gene expression programmes are faithfully transmitted within cell lineages and from one generation to the next?
  • How do RNA-RNA and RNA-protein interactions control gene expression at the post-transcriptional level?
  • How do DNA sequence variations influence gene expression and phenotypic outcomes, and what are the long-term consequences of this on an evolutionary time scale?
  • How can dynamic models help us to understand signalling, gene regulation and cell fate decision making?
  • Can we improve the speed and accuracy of existing data analysis strategies?
  • What are the upcoming challenges in data analysis?

This conference will be a unique opportunity for participants to learn about the latest discoveries, talk about their own findings and initiate research partnerships. As well as scientific sessions, there will be many networking opportunities, including poster sessions, a conference dinner and an excursion to nearby Kloster Eberbach monastery. We hope that the ideas and concepts developed during the conference will result in exciting collaborations. Anyone interested is welcome to attend and can register online.

www.imb.de/2017conference

9–10 October 2017 4th Annual Drug Discovery USA Congress

San Diego, USA

Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive platform for high level discussions, ensuring valuable networking and interactive sessions.

View Agenda: http://bit.ly/1Li0Wd4

4 Interactive Streams:

  • Drug Discovery Innovation and Strategies, Enabling Technologies for Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology
  • Successful Phenotypic Drug Discovery: High Content Screening
  • Discovery Chemistry: Medicinal and Computational Chemistry
  • Discovery Chemistry: Medicinal Chemistry and Novel Approaches to Drug Design

Free Webinar Recording:

Advance in Fragmented-based Drug Discovery
Hosted by Vincent Stoll, Associate Director of Structural Biology, AbbVie
Download for Free: http://bit.ly/2cuVKoT

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

http://bit.ly/1Li0Wd4

Journal Contact

MDPI AG
Genes Editorial Office
St. Alban-Anlage 66, 4052 Basel, Switzerland
E-Mail: 
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
Editorial Board
Contact Details Submit to Genes Edit a special issue Review for Genes
Back to Top